Xylem (NYSE:XYL) Stock Price Target Lowered at Citigroup

Key Points

• Citigroup lowered Xylem’s price target from $148 to $130 but maintained a “buy” rating, implying approximately 47% upside from the stock’s $88.31 price. The analyst consensus remains “Moderate Buy,” with an average target of $128.21.
• Xylem shares fell 4.9% after the company reported quarterly revenue of $2.20 billion and EPS of $1.44, both slightly below expectations. Revenue declined 3% year over year, while management’s reduced outlook and softer project and metering demand have prompted several analysts to cut targets or downgrade the stock.
• Analyst sentiment is mixed: ten analysts rate Xylem a Buy and eight rate it a Hold, while JPMorgan downgraded the stock to “neutral” and cut its target to $90. Institutional investors still own approximately 88% of the shares.

Xylem (NYSE:XYL - Get Free Report) had its price target dropped by equities research analysts at Citigroup from $148.00 to $130.00 in a report released on Wednesday, Benzinga reports. The brokerage presently has a "buy" rating on the industrial products company's stock. Citigroup's target price indicates a potential upside of 47.20% from the stock's current price.

Other research analysts have also issued research reports about the stock. JPMorgan Chase & Co. lowered shares of Xylem from an "overweight" rating to a "neutral" rating and lowered their price target for the stock from $118.00 to $90.00 in a report on Wednesday. Barclays reduced their price objective on shares of Xylem from $159.00 to $139.00 and set an "overweight" rating on the stock in a research note on Tuesday, October 13th. Wolfe Research assumed coverage on shares of Xylem in a research report on Tuesday, September 15th. They set a "peer perform" rating for the company. Stifel Nicolaus lowered their target price on shares of Xylem from $141.00 to $114.00 and set a "buy" rating for the company in a research note on Wednesday. Finally, BNP Paribas Exane dropped their target price on shares of Xylem from $145.00 to $135.00 and set an "outperform" rating on the stock in a report on Wednesday. Ten investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $128.21.

Xylem Trading Down 4.9%

Shares of NYSE XYL traded down $4.54 during trading on Wednesday, reaching $88.31. The company had a trading volume of 4,942,934 shares, compared to its average volume of 2,146,082. The stock has a market cap of $20.62 billion, a P/E ratio of 21.03, a PEG ratio of 1.75 and a beta of 1.00. The company's fifty day moving average price is $106.50 and its 200-day moving average price is $118.31. The company has a quick ratio of 1.24, a current ratio of 1.61 and a debt-to-equity ratio of 0.23. Xylem has a 12 month low of $87.40 and a 12 month high of $154.27.

Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings data on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.45 by ($0.01). Xylem had a return on equity of 11.77% and a net margin of 11.15%. The company had revenue of $2.20 billion for the quarter, compared to the consensus estimate of $2.28 billion. During the same quarter last year, the business earned $1.37 earnings per share. Xylem's revenue was down 3.0% compared to the same quarter last year. As a group, research analysts expect that Xylem will post 5.65 earnings per share for the current year.

Institutional Investors Weigh In On Xylem

Large investors have recently bought and sold shares of the stock. State Street Corp grew its position in Xylem by 2.4% in the 2nd quarter. State Street Corp now owns 11,444,669 shares of the industrial products company's stock worth $1,352,874,000 after purchasing an additional 270,972 shares in the last quarter. XXEC Inc. lifted its position in shares of Xylem by 477.9% during the 1st quarter. XXEC Inc. now owns 171,211 shares of the industrial products company's stock worth $20,460,000 after buying an additional 141,586 shares in the last quarter. Perpetual Ltd lifted its position in shares of Xylem by 10.2% during the 3rd quarter. Perpetual Ltd now owns 129,946 shares of the industrial products company's stock worth $13,160,000 after buying an additional 11,993 shares in the last quarter. NFJ Investment Group LLC purchased a new position in shares of Xylem in the 2nd quarter worth approximately $4,116,000. Finally, Entropy Technologies LP boosted its stake in shares of Xylem by 45.7% in the 1st quarter. Entropy Technologies LP now owns 36,956 shares of the industrial products company's stock worth $4,416,000 after buying an additional 11,583 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Xylem

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Third-quarter adjusted earnings increased year over year to $1.44 per share, and orders reportedly grew 10%, suggesting underlying demand remains resilient in some markets. Xylem Q3 2026 results
• Positive Sentiment: Several analysts still view the selloff as excessive. BNP Paribas Exane, Stifel Nicolaus and Oppenheimer maintained “outperform” or “buy” ratings, with revised targets of $135, $114 and $135, respectively—well above the current trading level. Analyst ratings
• Neutral Sentiment: Xylem plans portfolio divestitures and a segment restructuring. These actions could improve focus and efficiency over time, but may create near-term execution costs and uncertainty. Xylem restructuring plans
• Negative Sentiment: Third-quarter revenue was $2.20 billion, about $80 million below expectations and down 3% year over year. EPS of $1.44 also missed consensus, reflecting weakness in metering and delays or softness in project activity. Xylem Q3 earnings miss
• Negative Sentiment: Management cut its 2026 revenue and profit outlook and issued weak fourth-quarter expectations, raising concerns that customers are delaying purchases and that the slowdown may persist. Xylem outlook reduction
• Negative Sentiment: JPMorgan downgraded Xylem to “underweight” from “neutral” and cut its price target to $90 from $118. RBC and Oppenheimer also lowered targets, reinforcing concerns about earnings estimates. JPMorgan Xylem downgrade
• Negative Sentiment: Put-option purchases were roughly 358% above typical volume, signaling heightened downside hedging or bearish speculation. A law firm also announced an investigation into potential securities-law violations following the earnings-related losses. Xylem investigation notice

About Xylem

Xylem Inc NYSE: XYL is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company's products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.